Goldman Sachs Group Inc Simulations Plus, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 100,949 shares of SLP stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,949
Previous 49,335
104.62%
Holding current value
$1.62 Million
Previous $1.21 Million
45.66%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding SLP
# of Institutions
169Shares Held
17MCall Options Held
0Put Options Held
35.8K-
Black Rock Inc. New York, NY2.46MShares$39.5 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.28MShares$20.5 Million0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$18.8 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN875KShares$14 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X0813KShares$13 Million0.01% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $325M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...